COVID-19/runny nose/Cough/exhausted all the time; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (COVID-19/runny nose/Cough/exhausted all the time) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 037K20A) for COVID-19 vaccination.     The patient had no allergies (medications, food and other products). There was no other vaccines given within one month prior to Moderna COVID-19 vaccine.  Concurrent medical conditions included Blood pressure high (Started since 7 years. There was no recent change in status such as improvement or worsening.).   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In July 2022, the patient experienced COVID-19 (COVID-19/runny nose/Cough/exhausted all the time). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19/runny nose/Cough/exhausted all the time) had not resolved.            The patient was under regular medication for high blood pressure, but did not remember names. The reporter stated that the patient might have COVID-19 since 2 or 3 weeks ago the patient was experiencing symptoms like runny nose,Cough and was exhausted all the time. The patient did not experience a similar event in the past. The patient tried to get an appointment with their HCP, but unable to do it. Treatment also included other allergy medicine for his symptoms, but nothing worked.  Company Comment:  This is a spontaneous case concerning a 74-year-old male patient with no relevant medical history reported, who experienced the unexpected non-serious adverse event of special interest COVID-19, reported as patient might have COVID-19, which occurred approximately 9 months after receiving the first booster/third dose of mRNA-1273 vaccine. Patient had received 2-dose primary series of mRNA-1273 vaccine with given at an interval of 35 days which falls within the recommended vaccine dosing schedule, approximately 8 months prior to third mRNA-1273 vaccination. It was reported that the patient might have COVID-19 infection since the patient experienced runny nose, cough, and was exhausted all the time. Patient took Benadryl and other medications for allergy, however symptoms persisted. No further details about the diagnostic procedures were provided. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 74-year-old male patient with no relevant medical history reported, who experienced the unexpected non-serious adverse event of special interest COVID-19, reported as patient might have COVID-19, which occurred approximately 9 months after receiving the first booster/third dose of mRNA-1273 vaccine. Patient had received 2-dose primary series of mRNA-1273 vaccine with given at an interval of 35 days which falls within the recommended vaccine dosing schedule, approximately 8 months prior to third mRNA-1273 vaccination. It was reported that the patient might have COVID-19 infection since the patient experienced runny nose, cough, and was exhausted all the time. Patient took Benadryl and other medications for allergy, however symptoms persisted. No further details about the diagnostic procedures were provided. The benefit-risk relationship of mRNA-1273 is not affected by this report.